Rhenman & Partners Asset Management’s Immunovant IMVT Stock Holding History

Rhenman & Partners Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$443K	Sell
2024 Q4	$3.59M	Sell
2024 Q3	$6.93M	Buy
2024 Q2	$3.45M	Buy
2024 Q1	$4.05M	Sell
2023 Q4	$6.15M	Sell
2023 Q3	$6.38M	Buy
2023 Q2	$1.9M	Buy